These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11051217)

  • 1. Quetiapine: a review of its safety in the management of schizophrenia.
    Dev V; Raniwalla J
    Drug Saf; 2000 Oct; 23(4):295-307. PubMed ID: 11051217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine. A review of its use in the management of schizophrenia.
    Cheer SM; Wagstaff AJ
    CNS Drugs; 2004; 18(3):173-99. PubMed ID: 14871161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine: efficacy and tolerability in schizophrenia.
    Kasper S; Tauscher J; Heiden A
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S405-13. PubMed ID: 11587888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of quetiapine and its clinical applications in schizophrenia.
    Kasper S; Müller-Spahn F
    Expert Opin Pharmacother; 2000 May; 1(4):783-801. PubMed ID: 11249516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
    Kasper S; Brecher M; Fitton L; Jones AM
    Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.
    Wong YW; Yeh C; Thyrum PT
    J Clin Psychopharmacol; 2001 Feb; 21(1):89-93. PubMed ID: 11199955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on quetiapine.
    Green B
    Curr Med Res Opin; 1999; 15(3):145-51. PubMed ID: 10621920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine: a well-tolerated and effective atypical antipsychotic.
    Hellewell JS
    Hosp Med; 2002 Oct; 63(10):600-3. PubMed ID: 12422494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of quetiapine side effects.
    Garver DL
    J Clin Psychiatry; 2000; 61 Suppl 8():31-3; discussion 34-5. PubMed ID: 10811241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication.
    Hong WW; Rak IW; Ciuryla VT; Wilson AM; Kylstra JW; Meltzer HY; Carpenter WT; Lehman A; Arvanitis LA
    Schizophr Res; 1998 Jun; 32(1):51-8. PubMed ID: 9690334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine.
    Vesely C; Küfferle B; Brücke T; Kasper S
    Int Clin Psychopharmacol; 2000 Jan; 15(1):57-60. PubMed ID: 10836289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.